ATG5 and prostate neoplasm: ATG5 protein was frequently overexpressed in prostate tumours, but did not correlate with pathological parameters such as Gleason grade. Loss of ATG5 observed in 18% of the castration-resistant patients (Kharaziha et al., 2015)